None listed
Conditions
Brief summary
Musculoskeletal conditions are the most common cause of long-term pain and physical disability. Given the aging population, cost-effective approaches to treatment and management of myofascial pain are vital to reducing the burden of these conditions on our health delivery system. The current literature has suggests that magnet therapy may be a safe, non-invasive option in the treatment and management of MPS. The purpose of this study is to investigate the antinociceptive effects of quadripolar magnets in the treatment of myofascial pain syndrome.
Interventions
Subjects with a clinical diagnosis of cervicothoracic regional myofascial pain syndrome (MPS) will be randomly allocated to equal test and control groups; the test group will self-apply quadripolar magnets that contain two positive and two negative poles arranged in a circle. The magnets will be self-applied on the surface of the skin directly over a clinically identified myofascial trigger point locus in the supraspinatus muscle for seven days beginning immediately upon waking in the morning an
Subjects with a clinical diagnosis of cervicothoracic regional myofascial pain syndrome (MPS) will be randomly allocated to equal test and control groups; the test group will self-apply quadripolar magnets that contain two positive and two negative poles arranged in a circle. The magnets will be self-applied on the surface of the skin directly over a clinically identified myofascial trigger point locus in the supraspinatus muscle for seven days beginning immediately upon waking in the morning and removed before retiring for the evening. Subjects will also be asked to complete a daily pain questionnaire just after removing the magnet for the evening.
Sponsors
University of Guelph
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
A clinical diagnosis of regional myofascial pain syndrome (cervicothoracic) with identifiable bilateral myofascial trigger points within the supraspinatus muscle.
Exclusion criteria
patients using an electronic medical device (eg pacemaker), acute injury to cervicothoracic spine, history of autoimmune/connective tissue disorder/spinal surgery, current use of pain/anti-inflammatory medication, neurological conditions (neuropathy).
Outcome results
None listed